EUR 10.05
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 57.5 Million EUR | -3.93% |
2022 | 59.85 Million EUR | 10.57% |
2021 | 54.13 Million EUR | 82.32% |
2020 | 29.69 Million EUR | -2.93% |
2019 | 30.58 Million EUR | -12.22% |
2018 | 34.84 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 48.2 Million EUR | -16.17% |
2023 Q4 | 57.5 Million EUR | 7.59% |
2023 FY | 57.5 Million EUR | -3.93% |
2023 Q2 | 53.44 Million EUR | -10.71% |
2022 Q2 | 57.73 Million EUR | 6.66% |
2022 FY | 59.85 Million EUR | 10.57% |
2022 Q4 | 59.85 Million EUR | 3.66% |
2021 FY | 54.13 Million EUR | 82.32% |
2021 Q4 | 54.13 Million EUR | -0.45% |
2021 Q2 | 54.37 Million EUR | 83.15% |
2020 Q4 | 29.69 Million EUR | 0.0% |
2020 FY | 29.69 Million EUR | -2.93% |
2019 FY | 30.58 Million EUR | -12.22% |
2018 FY | 34.84 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
MPH Health Care AG | 266.35 Million EUR | 78.412% |
Dermapharm Holding SE | 2.18 Billion EUR | 97.367% |
Evotec SE | 2.29 Billion EUR | 97.499% |
MERCK Kommanditgesellschaft auf Aktien | 49.12 Billion EUR | 99.883% |
PharmaSGP Holding SE | 131.29 Million EUR | 56.207% |
SynBiotic SE | 34.91 Million EUR | -64.671% |